Saran, F., & Wick, W. (2016). Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: Comprehensive safety results during and after first-line therapy. Neuro-Oncology, 18(7), . https://doi.org/10.1093/neuonc/nov300
Chicago Style (17th ed.) CitationSaran, Frank, and Wolfgang Wick. "Bevacizumab, Temozolomide, and Radiotherapy for Newly Diagnosed Glioblastoma: Comprehensive Safety Results During and After First-line Therapy." Neuro-Oncology 18, no. 7 (2016). https://doi.org/10.1093/neuonc/nov300.
MLA (9th ed.) CitationSaran, Frank, and Wolfgang Wick. "Bevacizumab, Temozolomide, and Radiotherapy for Newly Diagnosed Glioblastoma: Comprehensive Safety Results During and After First-line Therapy." Neuro-Oncology, vol. 18, no. 7, 2016, https://doi.org/10.1093/neuonc/nov300.